X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-12-2023-46659.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/jb-pharma-acquires-cardiac-brand-from-glenmark-for-rs-314-crore/articleshow/96234363.cms
https://www.lexblog.com/2022/06/23/fda-issues-untitled-letter-to-althera-pharmaceuticals-statements-relating-to-roszet/
https://endpts.com/fda-slams-small-pharma-for-misleading-ad-with-a-dearth-of-safety-info-and-dubious-stat-calculations/
https://www.einnews.com/pr_news/555914224/now-available-generic-ezetimibe-rosuvastatin-combination-tablets-in-a-trial-80-of-chd-patients-reached-ldl-c-goal
https://psnc.org.uk/our-news/class-4-medicines-defect-informationrosuvastatin-5-mg-10-mg-20-mg-and-40-mg-film-coated-tablets/
https://www.prweb.com/releases/fda_approves_altheras_roszet_rosuvastatin_and_ezetimibe_tablets_a_new_oral_therapy_for_powerful_cholesterol_reduction/prweb17832549.htm
https://www.prnewswire.com/news-releases/grunenthal-closes-deal-with-astrazeneca-for-european-rights-to-crestor-rosuvastatin-301225603.html
http://www.pharmatimes.com/news/az_sells_rights_to_statin_med_crestor_to_grunenthal_1358771
https://pharmaphorum.com/news/az-says-recovery-to-continue-to-despite-patent-expiry-and-brexit-headwinds/
https://www.fiercepharma.com/pharma/astrazeneca-to-shell-out-ps12m-severance-dispute-workers-at-former-england-plant
https://www.biospectrumindia.com/news/43/14197/sun-pharma-launches-rosuvastatin-for-lipid-disorder-treatment.html
https://www.thecardiologyadvisor.com/home/topics/metabolic/dyslipidemia/fda-approves-sprinkle-formulation-of-rosuvastatin/
https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic
https://www.fiercepharma.com/pharma/eli-lilly-bms-among-77-drugmakers-targeted-chinese-financial-probe
https://www.biospectrumasia.com/news/33/13424/sandoz-receives-regulatory-approval-from-nmpa-for-rosuvastatin.html
https://www.reuters.com/article/us-astrazeneca-innate-pharma/astrazeneca-digs-deeper-into-cancer-with-innate-stake-idUSKCN1MX0FK
https://www.fiercepharma.com/pharma/cardiovascular-landscape-from-2017-to-2024-featuring-eliquis-xarelto-and-more
http://www.pharmatimes.com/news/astrazeneca_settles_seroquelcrestor_lawsuits_for_$110_million_1248068
https://uk.reuters.com/article/us-astrazeneca-texas-lawsuits/astrazeneca-settles-texas-drug-lawsuits-for-110-million-idUKKBN1KT0Q9
https://www.fiercepharma.com/pharma/medicare-direct-drug-price-negotiation-could-save-2-8b-a-year-senator-report
https://www.marketwatch.com/story/doctor-payments-increased-drug-prescribing-by-73-new-study-finds-2018-07-30
https://health.economictimes.indiatimes.com/news/pharma/new-drugs-help-as-astrazeneca-battles-through-generic-losses/65145275
https://www.fiercepharma.com/pharma/astrazeneca-s-new-launches-shine-q2-as-it-inches-toward-turnaround
http://www.pmlive.com/pharma_news/new_cancer_drugs_cant_quite_plug_the_revenue_hole_at_az_1245876
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-fixes-prices-of-22-drug-formulations/articleshow/64575442.cms
https://endpts.com/astrazeneca-writes-off-its-second-pivotal-copd-trial-for-fasenra-killing-expansion-plans/
https://www.fiercepharma.com/pharma/astrazeneca-s-q1-slips-crestor-could-a-trio-oncology-meds-deliver-for-2018
https://www.fiercepharma.com/pharma/busy-az-posts-q4-beats-as-execs-promise-light-at-end-tunnel
http://www.reuters.com/article/us-astrazeneca-results/astrazeneca-sales-decline-slows-as-it-waits-for-medicine-to-work-idUSKBN1D90ST
http://www.fiercepharma.com/pharma/decade-s-top-10-patent-losses-featuring-seismic-sales-shifts
http://www.reuters.com/article/us-health-heart-idUSKBN1A92LP?feedType=RSS&feedName=healthNews
http://www.fiercepharma.com/manufacturing/roche-recalls-valium-australia-after-tampering-uncovered
https://www.pharmacompass.com/pdf/news/apotex-recalls-btc-rosuvastatin-10-mg-tablets-due-to-this-medicine-may-have-been-dispensed-with-missing-blister-sheets-1495873376.pdf
https://economictimes.indiatimes.com/opinion/interviews/have-1-million-users-of-glucomonitor-in-india-sushil-suri-morepen-labs/articleshow/58475593.cms
https://www.securingindustry.com/pharmaceuticals/taiwan-fda-seeks-crestor-recall-after-counterfeit-find/s40/a3433/#.WMEFcdKGPIV
https://www.theguardian.com/business/nils-pratley-on-finance/2017/feb/08/gsk-needs-no-medicine-despite-talk-of-poor-performance
http://us.cnn.com/2017/02/02/health/trump-drugs-propecia/index.html
https://www.bloomberg.com/gadfly/articles/2017-01-18/astrazeneca-cancer-trial-changes-not-enough-to-catch-up
http://www.business-standard.com/article/companies/us-pricing-pressure-to-keep-pharma-companies-growth-under-check-117011500327_1.html
http://www.fiercepharma.com/pharma/drugmakers-have-hijacked-fda-s-orphan-system-to-score-pricing-protection-mass-market-meds
http://www.fiercepharma.com/pharma/medicare-medcaid-pony-up-for-big-price-hikes-2015-data-show
http://www.fiercepharma.com/pharma/fda-changes-citizen-petition-rules-to-avoid-undue-generic-delays
http://www.pharmatimes.com/news/az_q3_boosted_by_tax_gains,_currency_benefits_1176227
http://www.wsj.com/articles/astrazeneca-earnings-what-to-watch-1478629663?tesla=y
http://www.cordenpharma.com/press-release/cordenpharma-announces-new-highly-potent-api-process-bay-in-cordenpharma-colorado/
Market Place
Share 
